Offering Digital Adherence Support Improves Clinical Outcomes for High-risk Chronic Obstructive Pulmonary Disease (COPD) Patients with Poor Adherence to Inhaled Therapy
Price, D., Dickens, A. P., Henley, W., Skinner, D., Pinnock, H., van Boven, J. F., Roche, N., Kostikas, K., Beeh, K. M., Usmani, O., Clark, A., Chalmers, J. D., Kaplan, A., Carter, V., Smith, U., Burnett-Kirton, Z., White, S. M., Davis, S. R., Hannan, N., Igwe, F., Mastoridis, P., Mezzi, K., Pfister, P., Halpin, D. M.
American Thoracic Society Conference 2025, A1336
Contributions to Journals: Abstracts
[ONLINE] DOI:
[OPEN ACCESS]
Patterns of care in the management of high-risk COPD in Australia (2015–2019): observational study for the CONQUEST quality improvement program
Jenkins, C., Dickens, A. P., Evans, A., Le Cheng, P., Heraud, F., Hancock, K., Sharma, A., Cochrane,, B., Roussos, A., Le Lievre, C. E., Blakey, J. D., Bosnic-Anticevich, S., Carter, V., Catanzariti, A., Ghisla, C., Hew, M., Ko, B., Le, T., Leong, P., McDonald, V., Lau, C. M., Perret, J., Pullen, R., Ranasinghe, K., Soriano, J. B., Stewart, D., van Melle, M., Wiseman, R., Price, D.
The Lancet Regional Health - Western Pacific, vol. 58, 101555
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
The BETRI study: preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)
Piraino, A., Brusselle, G., Grainge, C., Roche, N., Gayle, A., Carter, V., Price, D., Di Palma, L., Singh, D.
American Thoracic Society Conference 2025, A1474
Contributions to Journals: Abstracts
[ONLINE] DOI:
[OPEN ACCESS]
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update
Larenas-Linnemann, D., Rhee, C. K., Altraja, A., Busby, J., Tran, T. N., Wang, E., Popov, T. A., Mitchell, P. D., Pfeffer, P. E., Pleasants, R. A., Katial, R., Koh, M. S., Bourdin, A., Schleich, F., Máspero, J., Hew, M., Peters, M. J., Jackson, D. J., Christoff, G. C., Perez-de-Llano, L., Cherrez-Ojeda, I., Fonseca, J. A., Costello, R. W., Torres-Duque, C. A., Kuna, P., Menzies-Gow, A. N., Stjepanovic, N., Gibson, P. G., Pitrez, P. M., Bergeron, C., Porsbjerg, C. M., Taillé, C., Taube, C., Papadopoulos, N. G., Papaioannou, A. I., Salvi, S., Canonica, G. W., Heffler, E., Iwanaga, T., Al-Ahmad, M. S., Lehmann, S., Al-Lehebi, R., Cosio, B. G., Perng, D., Mahboub, B., Heaney, L. G., Patel, P. H., Lugogo, N., Wechsler, M. E., Bulathsinhala, L., Carter, V., Fletton, K., Neil, D. L., Scelo, G., Price, D. B.
Tuberculosis & Respiratory Diseases, vol. 88, no. 2, pp. 193-215
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
Predicting risk of morbidities associated with oral corticosteroid prescription for asthma
Stanley, B., Chapaneri, J., Khezrian, M., Maslova, E., Patel, S., Gurnell, M., Canonica, G. W., Reddel, H. K., Heaney, L. G., Bourdin, A., Neilly, D., Carter, V., Price, D.
Pragmatic and Observational Research, vol. 2025, no. 16, pp. 95-109
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
The compAIR study: The carbon footprint of asthma inhalers before and after initiation of Fostair MART
Tyrer, F., Ramakrishnan, S., Jenkins, C., Crooks, M., Ariti, C., Bardin, P. G., Carter, V., Farah, C., Le Lievre, C. E., Pathak, S., Ravi, R., Roussos, A., Tham, M., Townend, J., Wark, P. A., Price, D.
REG Summit 2025
Contributions to Conferences: Posters
Time from initial referral for specialist care until biologic therapy prescription for patients with severe uncontrolled asthma
Price, D., Blakey, J., Busby, J., Chung, L. P., Hew, M., Hu, N., Jackson, D. J., Katsoulotos, G., Pinnock, H. J., Ryan, D. P., Thompson, P. J., Accalai, P., Heatley, H., Le Cheng, P., Le Lievre, C. E., Armstrong, T., Botini,, F., Bushell, N., Carter, V., Denton, E., Hancock, K. L., Heraud, F., Le, T., Morgan, L., Ranasinghe, K., Roussos, A., Stewart, D., Thien, F., Vincent, E., Xu Wen, A., Wiseman, R., Zubrinich, C.
REG Summit 2025
Contributions to Conferences: Posters
Systematic corticosteroid increases healthcare costs in Australian patients with asthma
Upham, J. W., Bosnic-Anticevich, S., Botini,, F., Bushell, N., Carter, V., Catanzariti, A., Shi Kai Chan, J., Le Cheng, P., Cochrane,, B., Crooks, W., Hancock, K., Hew, M., Heatley, H., Le Lievre, C. E., Le, T., Neil, D., Ranasinghe, K., Rigby, D., Roussos, A., Sharma, A., Smith, P., Stewart, D., Thompson, P., Wiseman, R., Price, D.
TSANZSRS 2025, pp. 11
Contributions to Journals: Abstracts
[ONLINE] DOI:
[OPEN ACCESS]
Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: the CLEAR Study
Tran, T. N., Chen, S., Emmanuel, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Cook, B., Bulathsinhala, L., Henley, W., Goh, C. Y., Liu, Y., Ariti, C., Carter, V., Price, D., CLEAR Study Working Group
Pragmatic and Observational Research, vol. 16, pp. 51-66
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
Adopting Australian Asthma Handbook's Option A could reduce carbon footprint
Smith, P., Bosnic-Anticevich, S., Botini,, F., Bushell, N., Carter, V., Catanzariti, A., Le Cheng, P., Cochrane,, B., Crooks, W., Hancock, K., Hew, M., Le Lievre, C. E., Le, T., Ranasinghe, K., Rigby, D., Roussos, A., Stewart, D., Thompson, P., Upham, J. W., Wiseman, R., Price, D.
